Kiniksa Pharmaceuticals officer sells 194k in stock

KNSA Stock  USD 21.32  0.19  0.88%   
About 62% of Kiniksa Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Kiniksa Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Kiniksa Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Kiniksa Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Kiniksa Pharmaceuticals officer sells 194k in stock

Read at investing.com
Investing News at Macroaxis
  

Kiniksa Pharmaceuticals Fundamental Analysis

We analyze Kiniksa Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kiniksa Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kiniksa Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Equity

Return On Equity Comparative Analysis

Kiniksa Pharmaceuticals is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Kiniksa Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kiniksa Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Kiniksa Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Kiniksa Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Kiniksa Pharmaceuticals Related Equities

CHRSCoherus BioSciences   12.58   
0%
100.0%
COGTCogent Biosciences   8.77   
0%
69.0%
KRONKronos Bio   8.51   
0%
67.0%
LYRALyra Therapeutics   5.00   
0%
39.0%
LRMRLarimar Therapeutics   4.64   
0%
36.0%
GPCRStructure Therapeutics   4.11   
0%
32.0%
PHATPhathom Pharmaceuticals   3.22   
0%
25.0%
GOSSGossamer Bio   2.67   
0%
21.0%
DAWNDay One   2.15   
0%
17.0%
NUVLNuvalent   0.42   
3.0%
0%
NVCTNuvectis Pharma   1.23   
9.0%
0%
KURAKura Oncology   1.31   
10.0%
0%
BOLTBolt Biotherapeutics   1.72   
13.0%
0%
ACLXArcellx   1.89   
15.0%
0%
SPROSpero Therapeutics   2.56   
20.0%
0%
CGEMCullinan Oncology   2.76   
21.0%
0%
REPLReplimune   3.36   
26.0%
0%
VTYXVentyx Biosciences   3.53   
28.0%
0%

Complementary Tools for Kiniksa Stock analysis

When running Kiniksa Pharmaceuticals' price analysis, check to measure Kiniksa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiniksa Pharmaceuticals is operating at the current time. Most of Kiniksa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiniksa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiniksa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiniksa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk